NO973340L - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme - Google Patents

Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme

Info

Publication number: NO973340L
Authority: NO; Norway
Prior art keywords: prophylaxis; obesity; preparation; treatment; pharmaceutical composition
Prior art date: 1995-01-20

Application number

NO973340A

Other languages

English (en)

Norwegian (no)

Other versions

NO973340D0 (no

Inventor

Niels Korsgaard

Michael Shalmi

Steven Bain

Birgitte Hjort Guldhammer

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-20

Filing date

1997-07-18

Publication date

1997-07-18

1997-07-18 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1997-07-18 Publication of NO973340D0 publication Critical patent/NO973340D0/no

1997-07-18 Publication of NO973340L publication Critical patent/NO973340L/no

Links

208000008589 Obesity Diseases 0.000 title abstract 2
235000020824 obesity Nutrition 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
238000011321 prophylaxis Methods 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
FNIBSWRSKVEZDZ-UHFFFAOYSA-N 3,4-diphenyl-3,4-dihydro-2h-chromene Chemical class C1OC2=CC=CC=C2C(C=2C=CC=CC=2)C1C1=CC=CC=C1 FNIBSWRSKVEZDZ-UHFFFAOYSA-N 0.000 title 1
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001302 tertiary amino group Chemical group 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO973340A 1995-01-20 1997-07-18 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme NO973340L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK6695		1995-01-20
DK77495		1995-06-30
PCT/DK1996/000011 WO1996022092A1 (fr)	1995-01-20	1996-01-10	Utilisation des 3,4-diphenylchromanes pour la preparation d'une composition pharmaceutique destinee au traitement preventif ou curatif de l'obesite

Publications (2)

Publication Number	Publication Date
NO973340D0 NO973340D0 (no)	1997-07-18
NO973340L true NO973340L (no)	1997-07-18

Family

ID=26063228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO973340A NO973340L (no)	1995-01-20	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme

Country Status (14)

Country	Link
US (1)	US6008242A (fr)
EP (1)	EP0804187A1 (fr)
JP (1)	JPH10512270A (fr)
KR (1)	KR19980701547A (fr)
CN (1)	CN1168099A (fr)
AU (1)	AU4328996A (fr)
BR (1)	BR9606925A (fr)
CA (1)	CA2208837A1 (fr)
CZ (1)	CZ211997A3 (fr)
HU (1)	HUP9800334A3 (fr)
IL (1)	IL116826A (fr)
NO (1)	NO973340L (fr)
TW (1)	TW448046B (fr)
WO (1)	WO1996022092A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910548B2 (en) *	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
WO1999002152A1 (fr) *	1997-07-10	1999-01-21	Novo Nordisk A/S	Utilisation de 3,4-diphenylchromanes pour la preparation d'une composition pharmaceutique permettant d'augmenter l'insulinosensitivite
EP1028724A1 (fr) *	1997-11-10	2000-08-23	Novo Nordisk A/S	Administration transdermique de 3,4-diarylchromanes
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
CA2581316C (fr)	2004-09-21	2013-09-10	Novogen Research Pty Ltd	Derives de chromane substitues, medicaments et utilisation a des fins therapeutiques
EP2635273B1 (fr)	2010-11-01	2020-01-08	MEI Pharma, Inc.	Compositions d'isoflavonoïdes et méthodes de traitement du cancer
MX368063B (es)	2014-02-07	2019-09-18	Novogen ltd	Compuestos de benzopirano funcionalizados y uso de los mismos.
CN116139125A (zh)	2015-02-02	2023-05-23	梅制药公司	联合治疗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3822287A (en) *	1969-04-17	1974-07-02	Rexall Drug Chemical	Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) *	1981-09-22	1984-05-08	Council Of Scientific And Industrial Research Rafi Marg	Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) *	1993-03-11	1994-01-18	Zymogenetics, Inc.	Methods for reducing bone loss using centchroman derivatives

1996
- 1996-01-09 TW TW085100184A patent/TW448046B/zh active
- 1996-01-10 CA CA002208837A patent/CA2208837A1/fr not_active Abandoned
- 1996-01-10 BR BR9606925A patent/BR9606925A/pt not_active Application Discontinuation
- 1996-01-10 EP EP96900092A patent/EP0804187A1/fr not_active Withdrawn
- 1996-01-10 JP JP8521977A patent/JPH10512270A/ja active Pending
- 1996-01-10 KR KR1019970704938A patent/KR19980701547A/ko not_active Withdrawn
- 1996-01-10 AU AU43289/96A patent/AU4328996A/en not_active Abandoned
- 1996-01-10 CN CN96191513A patent/CN1168099A/zh active Pending
- 1996-01-10 CZ CZ972119A patent/CZ211997A3/cs unknown
- 1996-01-10 HU HU9800334A patent/HUP9800334A3/hu unknown
- 1996-01-10 WO PCT/DK1996/000011 patent/WO1996022092A1/fr not_active Ceased
- 1996-01-11 US US08/585,013 patent/US6008242A/en not_active Expired - Fee Related
- 1996-01-19 IL IL11682696A patent/IL116826A/xx active IP Right Grant
1997
- 1997-07-18 NO NO973340A patent/NO973340L/no unknown

Also Published As

Publication number	Publication date
EP0804187A1 (fr)	1997-11-05
HUP9800334A2 (hu)	1998-12-28
BR9606925A (pt)	1997-11-11
CN1168099A (zh)	1997-12-17
HUP9800334A3 (en)	1999-12-28
CA2208837A1 (fr)	1996-07-25
TW448046B (en)	2001-08-01
WO1996022092A1 (fr)	1996-07-25
NO973340D0 (no)	1997-07-18
MX9705378A (es)	1997-10-31
KR19980701547A (ko)	1998-05-15
AU4328996A (en)	1996-08-07
CZ211997A3 (en)	1997-12-17
IL116826A0 (en)	1996-05-14
IL116826A (en)	1999-11-30
US6008242A (en)	1999-12-28
JPH10512270A (ja)	1998-11-24

Similar Documents

Publication	Publication Date	Title
BR0109703A (pt)	2003-02-04	Derivados de piperazina
NO20025821L (no)	2003-02-04	2-aminokarbonyl-9H-purinderivater
AP9701041A0 (en)	1999-01-10	Pyridylpyrrole compounds.
MXPA03008215A (es)	2004-01-29	Inhibidores de integrina alfa v beta 6.
NO996108L (no)	2000-02-10	9-oksinerytromycinderivater
NO983178L (no)	1998-07-10	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
ATE156804T1 (de)	1997-08-15	Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
AU1367497A (en)	1997-08-01	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
NO984470L (no)	1998-11-25	Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
GB9107827D0 (en)	1991-05-29	New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
NO20050664L (no)	2005-04-15	2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NZ300942A (en)	1998-12-23	1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
NO20050666L (no)	2005-03-11	2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
AU2001290480A1 (en)	2002-04-08	Cyclized benzamide neurokinin antagonists for use in therapy
NO973340L (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
DE69720715D1 (en)	2003-05-15	Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
NO973342L (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
MXPA04005809A (es)	2004-09-13	Inhibidores de proteinas quinasas.
NO973242L (no)	1997-07-11	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
NO973241L (no)	1997-07-11	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b
AU2001261707A1 (en)	2002-01-08	Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
TW349864B (en)	1999-01-11	Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
MXPA02002007A (es)	2003-08-20	Compuestos de bencimidazol sustituidos con alcoxi, preparaciones farmaceuticas que contienen los mismos, metodos para usarlos.
AU6519596A (en)	1997-02-05	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
NO973341L (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse